A Novel Prognostic Model of NPI for Risk-Predicting and Clinical Decision-making in Diffuse Large B-Cell Lymphoma in the Rituximab Era
Clinical trial NCT04624971 · UNKNOWN
Trial details
- NCT number
- NCT04624971
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-01
- Primary completion
- 2020-11-01
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.